EICHORCondition: Chemotherapy-induced Thrombocytopenia · Sponsor: Amgen
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
To evaluate the efficacy of romiplostim for the treatment of CIT in patients receiving chemotherapy for the treatment of NSCLC, ovarian cancer, or breast cancer measured by the ability to administer on-time, full-dose chemotherapy
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Saint Bernards Medical Center | Jonesboro, Arkansas, United States | — |
| Los Angeles Cancer Network | Anaheim, California, United States | — |
| University of California Irvine | Orange, California, United States | — |
| Colorado West Healthcare System dba Grand Valley Oncology | Grand Junction, Colorado, United States | — |
| University of Miami School of Medicine | Miami, Florida, United States | — |
| Ocala Oncology Center | Ocala, Florida, United States | — |
| Mid Florida Hematology and Oncology Centers PA | Orange City, Florida, United States | — |
| Saint Alphonsus Regional Medical Center | Boise, Idaho, United States | — |
| University of Chicago | Chicago, Illinois, United States | — |
| Orchard Healthcare Research Inc | Skokie, Illinois, United States | — |
| Christus Saint Frances Cabrini Hospital | Alexandria, Louisiana, United States | — |
| University Medical Center New Orleans | New Orleans, Louisiana, United States | — |
+ 127 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03937154